Growing community of inventors

Lexington, MA, United States of America

Santosh Ambadas Khedkar

Average Co-Inventor Count = 2.73

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Santosh Ambadas KhedkarLan Huang (2 patents)Santosh Ambadas KhedkarMark Feinberg (2 patents)Santosh Ambadas KhedkarMichel O Steinmetz (2 patents)Santosh Ambadas KhedkarDinesh U Chimmanamada (1 patent)Santosh Ambadas KhedkarS Ananth Karumanchi (1 patent)Santosh Ambadas KhedkarVivek Kannoth Vishnudas (1 patent)Santosh Ambadas KhedkarRavi Thadhani (1 patent)Santosh Ambadas KhedkarAlan C Rigby (1 patent)Santosh Ambadas KhedkarPeter M Kang (1 patent)Santosh Ambadas KhedkarMichel O Steinmetz (0 patent)Santosh Ambadas KhedkarSantosh Ambadas Khedkar (6 patents)Lan HuangLan Huang (23 patents)Mark FeinbergMark Feinberg (9 patents)Michel O SteinmetzMichel O Steinmetz (2 patents)Dinesh U ChimmanamadaDinesh U Chimmanamada (46 patents)S Ananth KarumanchiS Ananth Karumanchi (19 patents)Vivek Kannoth VishnudasVivek Kannoth Vishnudas (14 patents)Ravi ThadhaniRavi Thadhani (10 patents)Alan C RigbyAlan C Rigby (3 patents)Peter M KangPeter M Kang (3 patents)Michel O SteinmetzMichel O Steinmetz (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Beth Israel Deaconess Medical Center, Inc. (3 from 517 patents)

2. The Brigham and Women's Hospital, Inc. (2 from 1,386 patents)

3. Beyondspring Pharmaceuticals, Inc. (2 from 21 patents)

4. The General Hospital Corporation (1 from 2,896 patents)

5. Berg LLC (1 from 37 patents)


6 patents:

1. 12458639 - Tubulin binding compounds and therapeutic use thereof

2. 12428410 - Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells and cancer immunotherapy

3. 11633393 - Tubulin binding compounds and therapeutic use thereof

4. 11267807 - Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells and cancer immunotherapy

5. 11091447 - UBE2K modulators and methods for their use

6. 9499488 - Vitamin D receptor agonists and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/9/2026
Loading…